Published time:2006-10-16 Information sources:interlong
News in brief: on 25th of Sep, 2006, the clinical study summing-up meeting of Neptunus Interlong product rhIFN ¦Á2b liposome cream which is self-developed and independent property right protected was hold in Neptunus Mansion. Representing leadership of Neptunus Bioengineering Holiding Co., Ltd, vice General Manager Neptunus of Interlong Dr. Wang yan chaired this meeting and made an address to express our welcome to experts present. Among those present were experts from Institute of Dermatosis, Chinese Academy of Medical Sciences, Jilin University Secondly Hospital etc; the Clinical Stat. experts from Medical department of Shanghai Jiao Tong University and also the involved R&D researchers and marketing personnel. The clinical study was carried out to inspect the effects and safety of rhIFN ¦Á2b liposome cream for facial herpes simplex treatment, which adopts methods of multi-centers, randomized, double blinded and excipient parallel control. The meeting was held in a well academic atmosphere. In the meeting, experts analyzed and discussed the collected clinical statistical results and drew the conclusion of that rhIFN ¦Á2b liposome cream has good effects and safety for facial herpes simplex treatment.
Your
Current position:
